for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Celsion Announces Highly Encouraging Initial Clinical Results From The Phase I Portion Of The Phase I/II Ovation 2 Study With Gen-1 In Patients With Advanced Ovarian Cancer

March 19 (Reuters) - Celsion Corp:

* CELSION ANNOUNCES HIGHLY ENCOURAGING INITIAL CLINICAL RESULTS FROM THE PHASE I PORTION OF THE PHASE I/II OVATION 2 STUDY WITH GEN-1 IN PATIENTS WITH ADVANCED OVARIAN CANCER Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up